0001683168-22-006430.txt : 20220915
0001683168-22-006430.hdr.sgml : 20220915
20220915171050
ACCESSION NUMBER: 0001683168-22-006430
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220915
FILED AS OF DATE: 20220915
DATE AS OF CHANGE: 20220915
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ness Brent
CENTRAL INDEX KEY: 0001903562
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41358
FILM NUMBER: 221246420
MAIL ADDRESS:
STREET 1: 951 MARINERS ISLAND BLVD., SUITE 300
CITY: SAN MATEO
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aclarion, Inc.
CENTRAL INDEX KEY: 0001635077
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 473324725
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8181 ARISTA PLACE
STREET 2: STE 100
CITY: BROOMFIELD
STATE: CO
ZIP: 80021
BUSINESS PHONE: 833 275 2266
MAIL ADDRESS:
STREET 1: 8181 ARISTA PLACE
STREET 2: STE 100
CITY: BROOMFIELD
STATE: CO
ZIP: 80021
FORMER COMPANY:
FORMER CONFORMED NAME: Nocimed, Inc.
DATE OF NAME CHANGE: 20150226
4
1
ownership.xml
X0306
4
2022-09-15
0
0001635077
Aclarion, Inc.
ACON
0001903562
Ness Brent
8181 ARISTA PLACE
SUITE 100
BROOMFIELD
CO
80021
1
1
0
0
Chief Executive Officer
Options for Common Stock (right to buy)
1.94
2022-09-15
4
A
0
75582
0.00
A
2031-09-27
Common Stock
75582
416947
D
The shares underlying this option grant will vest in 48 equal monthly installments succeeding the vesting commencement date of September 1, 2021.
In accordance with the reporting person's employment agreement, on September 27, 2021 the reporting person was previously granted 341,365 options with substantially identical terms to the newly granted options reported herein. The options reported herein were granted in order to satisfy the equity grant target set forth in the reporting person's employment agreement.
/s/ Brent Ness
2022-09-15